The Claim
The accumulation of acetyl-CoA in rheumatoid synovial cells drives widespread histone and RNA acetylation, which enhances transcription and translation of pro-inflammatory genes, contributing to sustained synovial aggression and immune cell activation.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In rheumatoid synovial cells, increased levels of acetyl-CoA lead to chemical modifications on histones and RNA that increase the production of proteins involved in inflammation, resulting in persistent joint tissue damage and activation of immune cells.
See the scientific wording
The accumulation of acetyl-CoA in rheumatoid synovial cells drives widespread histone and RNA acetylation, which enhances transcription and translation of pro-inflammatory genes, contributing to sustained synovial aggression and immune cell activation.
Inflamed joint cells produce too much acetyl-CoA, which attaches to histones and RNA molecules, turning on genes that make inflammatory proteins and making those proteins easier to produce. This keeps the joint constantly inflamed and damages tissue.
What the research says
1 studyIn rheumatoid arthritis, joint cells build up too much acetyl-CoA, which acts like a switch that turns on inflammation genes and makes more inflammatory proteins, keeping the immune system stuck in overdrive. This study shows that this exact process is a major reason why the disease keeps coming back.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.